F.D.A. Panel Votes Against Expansion of Anticoagulant
Wednesday, May 23, 2012 - 23:50
in Health & Medicine
The Food and Drug Administration said concerns over bleeding outweighed the evidence that Xarelto reduced the risk of blood clots.